Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron

Nature
Volume 603 Issue 7901, 17 March 2022
https://www.nature.com/nature/volumes/603/issues/7901

 

Article | 31 January 2022 | Open Access
Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron
Current vaccines induce broadly cross-reactive cellular immunity against SARS-CoV-2 variants, including Omicron, and provide protection against severe disease despite a substantially reduced neutralizing antibody response.
Jinyan Liu, Abishek Chandrashekar, Dan H. Barouch